Treatments used by MS patients U.S. 2016

This statistic displays the percentage of treatments and therapies used by U.S. patients diagnosed with multiple sclerosis in 2016. As of that year, almost 70 percent of survey MS patients stated that they currently use prescribed some kind of disease-modifying therapy.

Percentage of U.S. patients diagnosed with multiple sclerosis using selected treatments in 2016

Characteristic	Never used	Used in the past, but no longer use	Currently use
Rx DMT (injectable, oral, and/or infusion/IV)	10%	21%	69%
Rx or OTC NSaids or other pain medications (ibuprofen, aleve, etc.)	18%	22%	59%
Complementary and alternative therapies (chiropractor, massage, yoga, vitamins, etc.)	34%	19%	47%
Other medication or treatment not listed	49%	15%	36%
Muscle relaxants (lioresal, valium, etc.)	54%	18%	28%
Neuromodulators or anticonvulsants (gabapentin, klonopin, etc.)	56%	18%	26%
Rehabilitation therapy (physical therapy, occupational therapy, etc.)	37%	49%	15%
Ampyra (dalfampridine)	76%	12%	12%
Chemotherapy (methotrexate, novantrone, etc.)	90%	9%	2%
Stem cell therapy/treatment	99%	1%	0.4%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

2016

More information

Region

United States

Survey time period

2016

Number of respondents

5,040 respondents

Special properties

diagnosed with MS

Method of interview

Online survey

Supplementary notes

Original questions: "Are you currently using, or have you ever used the following types of medications or treatments for your MS or its symptoms?" - "How long have you been using your current treatment plan?" - "How likely are you to change your treatment plan in the next 12 months?"

Citation formats